Full-Time

Planner

Confirmed live in the last 24 hours

Zoetis

Zoetis

5,001-10,000 employees

No salary listed

Senior

Kalamazoo, MI, USA

Category
Inventory Management
Production Planning & Scheduling
Supply Chain Management
Operations & Logistics
Required Skills
Supply Chain Management
SAP Products
Excel/Numbers/Sheets
Requirements
  • Minimum of Bachelor’s Degree in Management, Business Administration or related disciplines applicable to Supply Chain Management, Information Technology, or Pharmaceutical Manufacturing
  • Green Belt and APICS certification highly recommended
  • Minimum 5 years of relevant experience in Supply Chain, Manufacturing, Materials Management, and/or Marketing
  • Effective Written and Oral Communication Skills
  • Microsoft Applications and MRP/SAP system experience
  • Strong Excel experience
Responsibilities
  • Delivers efficient, effective, and flexible formulation plan to meet finished good production requirements
  • Responsible for managing inventory carrying costs (Raw/Packaging Materials, API, WIP) to corporate and site budget targets while satisfying customer demand with minimal over-supply and back orders
  • Execute Purchase Orders to schedule supply of materials to meet production requirements and minimum inventory levels
  • Understand and is responsible for managing the financial impact of Value Stream Supply Chain activities in relation to the overall Site objectives and goals
  • Serves as both the long-term Planner and short-term Scheduler for the Formulation value stream
  • Initiates and leads cross-functional continuous improvement projects
  • Key member of product launch teams and initiates SAP material set up and process flow while meeting appropriate project milestones and timelines
  • Authors and reviews Standard Operating Procedures as required
Desired Qualifications
  • Demonstrated understanding of Right First Time and Lean Manufacturing concepts and principles preferred

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Parsippany-Troy Hills, New Jersey

Founded

1952

Simplify Jobs

Simplify's Take

What believers are saying

  • Zoetis benefits from the growing animal health market, projected to reach $112.33 billion by 2030.
  • The rise of pet insurance boosts demand for Zoetis' advanced veterinary services and products.
  • Zoetis' focus on AI integration in diagnostics aligns with accelerating industry trends.

What critics are saying

  • Emerging biotech firms in animal health could threaten Zoetis' market share.
  • Departure of key legal personnel may cause transitional challenges in compliance areas.
  • Competitors' rapid digital solutions advancement may outpace Zoetis' technological offerings.

What makes Zoetis unique

  • Zoetis is the world's leading animal health company, showcasing strong market leadership.
  • The company launched Vetscan OptiCell, a screenless hematology analyzer, in January 2025.
  • Zoetis collaborates with Colorado State University to advance sustainable animal production research.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Hybrid Work Options

Company News

MarketBeat
Feb 27th, 2025
World Equity Group Inc. Invests $342,000 in Zoetis Inc. (NYSE:ZTS)

World Equity Group Inc. invests $342,000 in Zoetis Inc. (NYSE:ZTS).

MarketBeat
Feb 22nd, 2025
Tandem Investment Advisors Inc. Invests $32.19 Million in Zoetis Inc. (NYSE:ZTS)

Tandem Investment Advisors Inc. invests $32.19 million in Zoetis Inc. (NYSE:ZTS).

MarketBeat
Jan 17th, 2025
Miracle Mile Advisors LLC Makes New $272,000 Investment in Zoetis Inc. (NYSE:ZTS)

Miracle Mile Advisors LLC makes new $272,000 investment in Zoetis Inc. (NYSE:ZTS).

TipRanks
Jan 13th, 2025
Zoetis Highlights Growth at J.P. Morgan Conference

Zoetis announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference, showcasing its exemplary 2024 performance and strategic growth initiatives.

Stock Titan
Jan 7th, 2025
Is Zoetis Inc. (NYSE: ZTS) Overvalued? Or Is It Worth Buying Now?

BetterInvesting Magazine has selected Zoetis (NYSE: ZTS) as its 'Stock to Study' for the March 2025 issue, suggesting the stock warrants further investigation by investors.